Oncternal Therapeutics (NASDAQ:ONCT) versus Vertex Pharmaceuticals (NASDAQ:VRTX) Head to Head Survey
16.0% of Oncternal Therapeutics shares are owned by institutional investors. Comparatively, 91.0% of Vertex Pharmaceuticals shares are owned by institutional investors. 11.2% of Oncternal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback